30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Thornton Michael Milos

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Thornton Michael Milos's trades of ENDRA Life Sciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-22 2023-05-18
B Purchase
30,960 -24.7%
302.33
US$244,651 		30,960 -24.7% 302.33 US$244,651
2022-12-13 2022-12-09
B Purchase
94,356 -39.4%
87.53
US$1,221,518 		94,356 -39.4% 87.53 US$1,221,518
2022-08-24 2022-08-22
B Purchase
28,896 +46.5%
181.29
US$1,933,550 		28,896 +46.5% 181.29 US$1,933,550
2022-05-31 2022-05-26
B Purchase
25,000 +8.1%
0.21
US$5,250 		25,000 +8.1% 0.21 US$5,250
2022-05-23 2022-05-18
B Purchase
25,000 +8.8%
0.22
US$5,500 		25,000 +8.8% 0.22 US$5,500
2021-04-07 2021-04-07
PlS Planned sale
15,000 -5.5%
2.53
US$37,950 		15,000 -5.5% 2.53 US$37,950
2021-04-07 2021-03-29
PlS Planned sale
18,750 -6.4%
2.37
US$44,438 		18,750 -6.4% 2.37 US$44,438
2019-05-20 2019-05-16
B Purchase
30,000 +33.4%
1.13
US$33,900 		30,000 +33.4% 1.13 US$33,900